期刊文献+

鼻咽癌与miRNAs 被引量:3

Nasopharyngeal carcinoma and miRNAs
原文传递
导出
摘要 鼻咽癌(nasopharyngeal carcinoma,NPC)是一种多基因遗传性疾病,好发生于我国华南、东南亚及部分非洲地区。近年来随着分子生物学及其技术的迅速发展,人们对鼻咽癌发生、发展及其生物学行为的研究已进入基因水平。microRNA(miRNA)是一类广泛存在于动植物体内的非编码小RNA,主要参与基因转录后水平调控。随着对miRNA研究的深入,发现肿瘤的细胞分化障碍、增殖失控、细胞永生化与miRNA密切相关。人类肿瘤组织与正常细胞组织间的miRNA表达水平和类型存在明显差异,提示miRNA可能是一类新的参与肿瘤发生的重要分子。本文就鼻咽癌与miRNA相关的研究进展作一综述。 Nasopharyngeal carcinoma (NPC) is a polygenic disease, and widely prevalent in the southern China, southeast Asia and parts of Africa. In recent years, with the rapid development of molecular biology and technology, the study of mechanism in NPC has entered gene level, microRNAs (miRNAs) are small non-coding RNAs regulation post-transcriptional level. With the depth of miRNA research, tumor cell differentiation, proliferation and immortalization are closely related with miRNAs. The significantly different miRNA profiles between NPC specimens and normal nasopharyngeal epithelium suggest that miRNAs may be a new class of important carcinogenesis molecules. In this paper, the NPC and its related-miRNAs were reviewed.
出处 《现代生物医学进展》 CAS 2011年第13期2565-2567,共3页 Progress in Modern Biomedicine
关键词 鼻咽癌 MIRNA Nasopharyngeal carcinoma miRNA
  • 相关文献

参考文献24

  • 1Farazi TA, Spitzer JI, Morozov P, et al. miRNAs in human cancer[J]. J Pathol, 2011,223(2):102-115.
  • 2Calin GA, Dumitru CD, Shimizu M, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miRl6 at 13q14 in chronic lymphocytic leukemia[J]. PNAS, 2002, 99(24): 15524-15529.
  • 3Chapiro E, Russell LJ, Struski S, et al. A new recurrent translocation t (11;14)(q24;q32) involving IGH@ and miR-125b-I in B-cell progenitor acute lymphoblastic leukemia [J]. Leukemia,2010, 24 (7): 1362-1364.
  • 4Linnstaedt SD, Gottwein E, Skalsky RL, et al. Virally induced cellular microRNA miR-155 plays a key role in B-cell immortalization by Epstein-Barr virus[J]. J Virol, 2010, 84(22): 11670-11678.
  • 5Calin GA, Croce CM. Chronic lymphocytic leukemia: interplay between noncoding RNAs and protein-coding genes [J]. Blood, 2009, 114(23): 4761-4770.
  • 6Iorio MV, Ferracin M, Liu CG, et al. microRNA gene expression deregulation in human breast cancer [J]. Cancer Res, 2005, 65(16): 7065-7070.
  • 7Yanaihara N, Caplen N, Bowman E, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis [J]. Cancer Cell, 2006, 9(3): 189-198.
  • 8Landi MT, Zhao Y, Rotunno M, et al. microRNA expression differentiates histology and predicts survival of lung cancer [J]. Clin Cancer Res,2010, 16(2): 430-441.
  • 9Lu J, Tsourkas A. Quantification of miRNA abundance in single cells using locked nucleic acid-FISH and enzyme-labeled fluorescence[J]. Methods Mol Biol, 2011,680:77-88.
  • 10Sethupathy P, Borel C, GagnebinM, et al. Human micr oRNA-155 on chromosome 21 differentially interactswith its polymorphic target in the AGTR1 YunWanslated region: a mechanism for functional singlenucleotide polymor phisms related to phenotypes [J]. Am J Hum Genet, 2007, 81 (2): 405-413.

二级参考文献31

  • 1宗永生,吴秋良,林素暇,何洁华,张昌卿.EB病毒相关性疾病病理学研究的进展[J].中山大学学报(医学科学版),2005,26(5):481-487. 被引量:27
  • 2Zhang B,Wang X,Wang Y.Altered gene expression and miRNA expression associated with cancerous IEC-6 cell transformed by MNNG[J].J Exp Clin Cancer Res,2009,28(1):56.
  • 3Sato F,Tsuchiya S,Terasawa K,et al.Intra-platform repeatability and inter-platform comparability of microRNA microarray technology[J].PLoS One,2009,4(5):e5540.
  • 4Willenbrock H,Salomon J,Sokide R,et al.Quantitative miRNA expression analysis:comparing microarrays with next-generation sequencing[J].RNA,2009,15(11):2028-2034.
  • 5Mallick B,Ghosh Z,Chakrabarti J.MicroRNome analysis unravels the molecular basis of SARS infection in bronchoalveolar stem cells[J].PLoS One,2009,4(11):e7837.
  • 6Bartel D P.MicroRNAs:genomics,biogenesis,mechanism,a-nd function[J].Cell,2004,116(2):281-297.
  • 7Ambros V.The functions of animal microRNAs[J].Nature,2004,431(7006):350-355.
  • 8Bishop J M.Molecular themes in oncogenesis[J].Cell,1991,64(2):235-248.
  • 9Weinberg R A.Tumor suppressor genes[J].Science,1991,254(5035):1138-1146.
  • 10Mcmanus M T.MicroRNAs and cancer[J].Semin Cancer Biol,2003,13(4):253-258.

共引文献20

同被引文献24

  • 1李晓霞,李瑞平,杜紫明,曾木圣,邵建永.鼻咽癌差异表达miRNAs筛选研究[J].中山大学学报(医学科学版),2007,28(6):607-612. 被引量:19
  • 2Tomokazu Yoshizaki,Makoto Ito,Shigekyuki Murono,Naohiro Wakisaka,Satoru Kondo,Kazuhira Endo.Current understanding and management of nasopharyngeal carcinoma[J].Auris Nasus Larynx.2011(2)
  • 3Jin-Xin Bei,Wei-Hua Jia,Yi-Xin Zeng.Familial and large-scale case–control studies identify genes associated with nasopharyngeal carcinoma[J].Seminars in Cancer Biology.2012(2)
  • 4Alan N. Gordon,Michael Teneriello,Mike F. Janicek,Jeffrey Hines,Peter C. Lim,M. Dwight Chen,Luis Vaccarello,Howard D. Homesley,Scott McMeekin,Tiana L. Burkholder,Yanping Wang,Luping Zhao,Mauro Orlando,Coleman K. Obasaju,John F. Gill,Datchen F. Tai.Phase III trial of induction gemcitabine or paclitaxel plus carboplatin followed by paclitaxel consolidation in ovarian cancer[J].Gynecologic Oncology.2011(3)
  • 5K Isobe,H Ito,N Shigematsu,T Kawada,S Yasuda,R Hara,N Machida,H Takano,Y Uchida,T Uno,H Kitahara,A Kubo.Advanced nasopharyngeal carcinoma treated with chemotherapy and radiotherapy:distant metastasis and local recurrence.[J].International Journal of Oncology.1998(5)
  • 6周袁申,麦润汝,邹旭.中医药治疗鼻咽癌放疗不良反应的研究进展[J].浙江中医药大学学报,2009,33(1):142-143. 被引量:22
  • 7衷敬华,刘瑞林,陈晶,张积仁,胡喜钢,王黎青,王勇.吉西他滨治疗复发转移性晚期鼻咽癌的系统评价[J].循证医学,2009,9(3):161-167. 被引量:8
  • 8司勇锋,陶仲强.鼻咽癌病因学和防治研究[J].中国耳鼻咽喉头颈外科,2010,17(3):163-165. 被引量:16
  • 9敬敏,陈小毅.miRNAs与鼻咽癌研究进展[J].肿瘤防治研究,2010,37(4):471-473. 被引量:1
  • 10景艳,唐安洲.中药在鼻咽癌综合治疗中的研究进展[J].实用医学杂志,2010,26(9):1487-1489. 被引量:17

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部